 Anti-Asthmatic Agents
"Anti-Asthmatic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that are used to treat asthma.
| Descriptor ID |
D018927
|
| MeSH Number(s) |
D27.505.954.796.050
|
| Concept/Terms |
Anti-Asthmatic Agents- Anti-Asthmatic Agents
- Agents, Anti-Asthmatic
- Anti Asthmatic Agents
- Anti-Asthmatics
- Anti Asthmatics
- Antiasthmatic Drugs
- Drugs, Antiasthmatic
- Antiasthmatics
- Anti-Asthmatic Drugs
- Anti Asthmatic Drugs
- Drugs, Anti-Asthmatic
- Antiasthmatic Agents
- Agents, Antiasthmatic
|
Below are MeSH descriptors whose meaning is more general than "Anti-Asthmatic Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Asthmatic Agents".
This graph shows the total number of publications written about "Anti-Asthmatic Agents" by people in this website by year, and whether "Anti-Asthmatic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 | | 1998 | 1 | 0 | 1 | | 2000 | 2 | 2 | 4 | | 2001 | 2 | 0 | 2 | | 2002 | 2 | 0 | 2 | | 2003 | 4 | 1 | 5 | | 2004 | 5 | 2 | 7 | | 2005 | 3 | 1 | 4 | | 2006 | 7 | 2 | 9 | | 2007 | 2 | 3 | 5 | | 2008 | 6 | 7 | 13 | | 2009 | 5 | 2 | 7 | | 2010 | 4 | 2 | 6 | | 2011 | 5 | 4 | 9 | | 2012 | 1 | 6 | 7 | | 2013 | 5 | 2 | 7 | | 2014 | 3 | 2 | 5 | | 2015 | 7 | 1 | 8 | | 2016 | 10 | 4 | 14 | | 2017 | 8 | 4 | 12 | | 2018 | 10 | 3 | 13 | | 2019 | 8 | 1 | 9 | | 2020 | 7 | 0 | 7 | | 2021 | 9 | 1 | 10 | | 2022 | 10 | 0 | 10 | | 2023 | 9 | 0 | 9 | | 2024 | 8 | 7 | 15 | | 2025 | 18 | 1 | 19 | | 2026 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Anti-Asthmatic Agents" by people in Profiles.
-
Davis AE, Rhoads S, Wechsler ME. Emerging biologic targets in type 2 and non-type 2 asthma. Curr Opin Pulm Med. 2026 May 01; 32(3):210-219.
-
Oberle AJ, Abbas F, Adrish M, Agache I, Conroy M, Coz Yataco AO, Little FF, Mammen MJ, Anand MP, Reddy R, Solanki N, Holguin F. Biologic Management in Severe Asthma for Adults: An American College of Chest Physicians Clinical Practice Guideline. Chest. 2026 Feb; 169(2):336-348.
-
Tomasello A, Szefler SJ, Cahill KN. Emerging Systemic Treatments for Asthma and Allergic Diseases: New Tricks, Same Dog? J Allergy Clin Immunol Pract. 2026 Feb; 14(2):325-335.
-
Harvey ES, Hamada Y, Hiles SA, Langton D, Thomas D, McDonald VM, Bardin P, Peters M, Reynolds PN, Upham JW, Blakey J, Bowler S, Chien J, Chung LP, Farah CS, Gillman A, Harrington J, Hew M, Jenkins C, Katelaris CH, Katsoulotos GP, Kritikos V, Lee J, Radhakrishna N, Sivakumaran P, Wark PAB, Gibson PG. Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry. Respir Med. 2025 Nov; 248:108340.
-
Wang E, Henley W, Larenas-Linnemann D, Bulathsinhala L, Tran TN, Wechsler ME, Aaron SD, Al-Ahmad M, Al-Lehebi R, Altraja A, Barker P, Beastall A, Belevskiy AS, Bergeron C, Bjermer L, Björnsdóttir US, Bosnic-Anticevich SZ, Bourdin A, Brusselle GG, Busby J, Canonica GW, Carter V, Chapman KR, Chapman N, Christoff GC, Cosio BG, Costello RW, Fingleton J, Fonseca JA, Gaga M, Gibson PG, Hansen S, Heaney LG, Heffler E, Hew M, Horiguchi T, Hoyte F, Hubbard RB, Iwanaga T, Jackson DJ, Katial R, Koh MS, Kostikas K, Kuna P, Lehmann S, Lehtimäki L, Louis R, Lúdvíksdóttir D, Lugogo N, Mahboub B, Martin N, Máspero J, Menzies-Gow AN, Mohan A, Murray RB, Nagano T, Papadopoulos NG, Papaioannou AI, Patel PH, Perez-de-Llano L, Perng DW, Peters MJ, Pfeffer PE, Pitrez PM, Pleasants RA, Popov TA, Porsbjerg CM, Puggioni F, Quinton A, Rhee CK, Sadatsafavi M, Salvi S, Scioscia G, Sheu CC, Sirena C, Taillé C, Taube C, Torres-Duque CA, Tsai MJ, Tunsäter A, Ulrik CS, Price DB. Response to Biologics Along a Gradient of T2 Involvement in Patients With Severe Asthma: A Data-Driven Biomarker Clustering Approach. J Allergy Clin Immunol Pract. 2025 Dec; 13(12):3296-3315.
-
Pavord I, Katial RK, Jackson DJ, Rogers L, Lega Hoyte FC, Smolen J, Wechsler ME, Akuthota P, Jackson DJ. Current data on biologics: Evaluating clinical remission in asthma. J Allergy Clin Immunol. 2025 Sep; 156(3S):S15-S19.
-
Sadatsafavi M, Tran TN, Scelo G, Tsai MJ, Busby J, Emmanuel B, Heaney LG, Jenkins C, Hoyte F, Canonica GW, Katial R, Heffler E, Wang E, Puggioni F, Wechsler ME, Ardusso LRF, Máspero J, Sivori M, Emmas C, Menzies-Gow AN, Stjepanovic N, Bosnic-Anticevich SZ, Cochrane B, Denton E, Gibson PG, Hew M, Middleton PG, Peters MJ, Brusselle GG, Louis R, Schleich F, Christoff GC, Popov TA, Bergeron C, Bhutani M, Chapman KR, Côté A, Couillard S, Dorscheid DR, Jiménez-Maldonado L, Solarte I, Torres-Duque CA, Hansen S, Porsbjerg CM, Ulrik CS, Altraja A, Bourdin A, Exarchos KP, Gogali A, Kostikas K, Makris MP, Papaioannou AI, Mitchell PD, Iwanaga T, Nagano T, Tohda Y, Al-Ahmad MS, Larenas-Linnemann D, Aarli BB, Kuna P, Chaves Loureiro C, Al-Lehebi R, Bulkhi AA, Chen W, Juang YR, Koh MS, Liu A, Rhee CK, Cosio BG, Perez-de-Llano L, Perng DW, Sheu CC, Wang HC, Mahboub B, Salameh L, Jackson DJ, Patel PH, Pfeffer PE, Lugogo N, Pleasants RA, Beastall A, Bulathsinhala L, Carter V, Eleangovan N, Fletton K, Townend J, Murray RB, Price DB. Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with Biologics. Am J Respir Crit Care Med. 2025 Jul; 211(7):1165-1174.
-
Hamada Y, Thomas D, McDonald VM, Harvey ES, Fricker M, Gillman A, Hew M, Kritikos V, Upham JW, Gibson PG. Impact of clinical remission on quality of life in severe eosinophilic asthma treated with mepolizumab. Ann Allergy Asthma Immunol. 2025 Nov; 135(5):537-546.e12.
-
Rayner DG, Bakaa L, Hoyte F, Perry TT, Rivera-Spoljaric K, Sumino K, Chipps B, Oppenheimer J, Nyenhuis SM, Israel E, McCabe E, O'Byrne PM, Shade LE, Press VG, Guyatt GH, Rangel S, Sue-Wah-Sing D, Hall L, Orr H, Melendez A, Winders T, Gardner DD, Przywara K, Rank MA, Bacharier LB, Mosnaim G, Chu DK. Triple therapy vs dual inhaler therapy for moderate-to-severe asthma: An updated systematic review and meta-analysis. Ann Allergy Asthma Immunol. 2025 Sep; 135(3):278-286.e11.
-
Althoff MD, Holguin F. Care of the Patient With Asthma. Ann Intern Med. 2025 Jun; 178(6):ITC81-ITC96.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|